GROUPE BERKEM |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.44 EUR | +2.86% |
|
0.00% | -52.94% |
| 02-06 | Givaudan: agreement signed with Berkem | CF |
| 02-06 | Groupe Berkem to Buy Spanish Industrial Site from Givaudan | MT |
| Sales 2023 | 52.4M 56.03M 76.58M | Sales 2024 * | 59.8M 63.94M 87.39M | Capitalization | 25.45M 27.21M 37.19M |
|---|---|---|---|---|---|
| Net income 2023 * | 2M 2.14M 2.92M | Net income 2024 * | 1M 1.07M 1.46M | EV / Sales 2023 | 1.03 x |
| Net Debt 2023 * | 16.43M 17.57M 24.02M | Net Debt 2024 * | 18.93M 20.24M 27.67M | EV / Sales 2024 * | 0.74 x |
| P/E ratio 2023 * |
10.8
x | P/E ratio 2024 * |
13.5
x | Employees | 234 |
| Yield 2023 * |
4.17% | Yield 2024 * |
2.08% | Free-Float | 31.92% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +2.86% | ||
| Current month | -25.00% | ||
| 1 month | -24.61% | ||
| 3 months | -53.85% | ||
| 6 months | -14.29% | ||
| Current year | -52.94% |
1 week
1.35
1.45
1 month
1.351.94
Current year
1.353.70
1 year
1.186.10
3 years
1.1810.50
5 years
1.1810.50
10 years
1.1810.50
| Managers | Title | Age | Since |
|---|---|---|---|
Olivier Fahy
CEO | Chief Executive Officer | 58 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Olivier Fahy
CEO | Chief Executive Officer | 58 | - |
Fahy Stanislas
BRD | Director/Board Member | - | 21-03-07 |
Lambert Thierry
BRD | Director/Board Member | - | 21-03-07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 1.44 | +2.86% | 9,682 |
| 24-04-25 | 1.4 | 0.00% | 10,037 |
| 24-04-24 | 1.4 | -0.71% | 33,862 |
| 24-04-23 | 1.41 | -0.70% | 20,120 |
| 24-04-22 | 1.42 | -1.39% | 9,560 |
Real-time Euronext Paris, April 26, 2024 at 11:35 am
More quotes
Berkem Group is a chemical group organized around 4 business units:
- production of active ingredients: from the extraction of plant materials. In addition, the group offers freeze-drying services for the food, cosmetics, nutraceutical and pharmaceutical industries, etc.;
- formulation of solutions for the preservation and protection of materials: in particular wood materials;
- distribution of solutions for the treatment, machining and protection of wood materials;
- manufacture of alkyd resins: for the paint, construction, wood treatment and ink industries.
At the end of 2021, the company has 3 production sites located in France.
France accounts for 79% of net sales.
Sector
Pharmaceuticals
Calendar
2024-04-28
- Q1 2024 Sales and Revenue Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.44
EUR
Average target price
5.633
EUR
Spread / Average Target
+291.20%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -52.94% | 27.17M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- ALKEM Stock
